📢 Heike Wiese, Head of New Modalities LCMS at NUVISAN will present on Metabolomics screening kits for use in clinical trials at Pharma Conclave 2024 on October 23 from 10:00 to 10:30 CET. Join us for this insightful virtual event featuring Heike Wiese and many other industry experts. ➡ https://lnkd.in/exGRqvCm
🧬 Pharma Conclave series 2024 Are you ready to explore the magic behind bringing new treatments to patients? Join us for an exclusive virtual event that connects every stage of the pharmaceutical development process. 📅 October 23-24, 2024 🕒 10:00 AM - 12:00 PM CET Topics include: ➡️ "Sphingolipid biomarkers in neurodegenerative drug development" by Ams Labs ➡️ "Development of an LC-MS method to quantify endogenous urea in mouse plasma and BAL" by Cyprotex ➡️ "Metabolomics screening kits for use in clinical trials" by Nuvisan ➡️ "PFAS Analysis and Mass Spectrometry" by Merieux Register now to secure your spot at the forefront of pharmaceutical innovation! 👉 https://bit.ly/3vUbcao #PharmaConclave2024 #DrugDiscovery #PharmaceuticalScience #PFAS #Metabolomics